BioLineRx (BLRX) Inventory Average (2023 - 2025)

BioLineRx's Inventory Average history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Inventory Average fell 35.28% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 35.28% YoY), while the FY2025 annual figure was $2.6 million, up 3.83% from the prior year.
• Inventory Average was $2.2 million for Q4 2025 at BioLineRx, down from $2.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $3.6 million in Q3 2024 to a low of $1.7 million in Q4 2023.
• Historically, Inventory Average has averaged $2.8 million across 3 years, with a median of $3.1 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory Average surged 102.39% in 2024, then plunged 35.28% in 2025.
• A 3-year view of Inventory Average shows it stood at $1.7 million in 2023, then soared by 102.39% to $3.3 million in 2024, then plunged by 35.28% to $2.2 million in 2025.
• The last three Inventory Average figures came in at $2.2 million (Q4 2025), $2.5 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.